SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Raffaele MarfellaCelestino SarduNunzia D'OnofrioCarlo FumagalliLucia ScisciolaFerdinando Carlo SassoMario SiniscalchiLudovica Vittoria MarfellaDavide D'AndreaFabio MinicucciGiuseppe SignorielloArturo CesaroMaria Consiglia TrottaChiara FrigéFrancesco PrattichizzoMaria Luisa BalestrieriAntonio CerielloPaolo CalabròCiro MauroLuca Del ViscovoGiuseppe PaolissoPublished in: BMC medicine (2023)
SGLT2i treatment in T2DM is associated with a reduced incidence of ISR-related events, independently of glycemic control.